Janux Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell JANX and other ETFs, options, and stocks.About JANX
Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded by David Campbell in June 2017 and is headquartered in San Diego, CA.
CEODavid Campbell
CEODavid Campbell
Employees81
Employees81
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2017
Founded2017
Employees81
Employees81
JANX Key Statistics
Market cap1.56B
Market cap1.56B
Price-Earnings ratio-20.42
Price-Earnings ratio-20.42
Dividend yield—
Dividend yield—
Average volume828.92K
Average volume828.92K
High today$28.39
High today$28.39
Low today$25.81
Low today$25.81
Open price$27.95
Open price$27.95
Volume906.68K
Volume906.68K
52 Week high$71.71
52 Week high$71.71
52 Week low$22.48
52 Week low$22.48
Analyst ratings
93%
of 14 ratingsBuy
92.9%
Hold
7.1%
Sell
0%
People also own
Based on the portfolios of people who own JANX. This list is generated using Robinhood data, and it’s not a recommendation.